Seed Life Science Companies

AbInitio Bio develops AI foundation models for biologic drug manufacturability and process optimization.

Imperagen is a biotechnology research company focused on enzyme engineering, artificial intelligence, and synthetic biology.

AI-powered medical imaging platform enabling hospitals and labs to deploy and scale digital pathology and radiology workflows.

Century Health accelerates drug development and commercialization by applying AI to real-world clinical data.

Avant Genomics is a biotechnology company that develops automated laboratory solutions for genomic and cancer research.

Tolemy Bio develops AI-driven tools to design, optimize, and control cell culture processes for advanced therapies.

Niche Biopharmaceuticals biopharma company that offers anti-infective immunomodulatory therapeutics for antiviral treatment.

Esphera SynBio operates as a biotechnology company.

Sedivention is a medtech startup that develops medical technology for minimally invasive obesity treatment through cryo-ablation procedures.

Modicus Prime enables pharmaceutical manufacturers to deploy AI systems that are auditable and compliant by design.

CELYSTRA Pharma identifies, licenses, and commercializes innovative therapies for rare and underserved diseases in Canada.

Locksmith Bio is a biotechnology company that uses AI to map intrinsically disordered protein for novel drug discovery.

Tacalyx is a biotech company that develops therapies that target cancer by focusing on tumor-associated carbohydrate antigens.

10x Science offers an AI software that analyzes protein data to characterize molecular structures and support biopharmaceutical research.

TAVRA Biosciences is a biotech company that offers cGMP‑manufactured stem cell products for the treatment of inflammation and injuries.

Drug-Delivery Technology

DeepCyte is a biotechnology company that offers predictive products for toxicology using single-cell metabolomics technology.

Exobiosphere is a cutting-edge company operating at the intersection of space exploration and biotechnology.

Stratum Biosciences focuses on leveraging artificial intelligence alongside biomarker discovery to create new dermatological therapies.

Cellbricks is a Berlin- and Boston-based biotech, pioneering the future of tissue and organ replacement.

Ritivel develops AI native regulatory workforce platform for regulatory and medical writing teams at life science companies.

Origin is a biotech company that creates patient-derived cancer single-cell dataset for licensing to pharmaceutical and AI companies.

Synthetic Sciences builds AI agents that automate research workflows, from literature review to experiments and papers.

Excalipoint Therapeutics develops targeted therapies that focus on modulating disease pathways at specific biological points.

Alomana harnesses artificial intelligence and data analytics to drive insights and innovation across various industries.